BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19577435)

  • 1. In vitro susceptibility of Burkholderia pseudomallei to antimicrobial peptides.
    Kanthawong S; Nazmi K; Wongratanacheewin S; Bolscher JG; Wuthiekanun V; Taweechaisupapong S
    Int J Antimicrob Agents; 2009 Oct; 34(4):309-14. PubMed ID: 19577435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial and antibiofilm activity of LL-37 and its truncated variants against Burkholderia pseudomallei.
    Kanthawong S; Bolscher JG; Veerman EC; van Marle J; de Soet HJ; Nazmi K; Wongratanacheewin S; Taweechaisupapong S
    Int J Antimicrob Agents; 2012 Jan; 39(1):39-44. PubMed ID: 22005071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial activity of cathelicidin peptides against Burkholderia pseudomallei, the causative agent of melioidosis.
    Sim SH; Liu Y; Tan J; Thong TW; Wang D; Ooi EE; Tan G
    Int J Antimicrob Agents; 2011 Sep; 38(3):270-1. PubMed ID: 21782393
    [No Abstract]   [Full Text] [Related]  

  • 4. D-LL-31 in combination with ceftazidime synergistically enhances bactericidal activity and biofilm destruction in
    Wongkaewkhiaw S; Taweechaisupapong S; Anutrakunchai C; Nazmi K; Bolscher JGM; Wongratanacheewin S; Kanthawong S
    Biofouling; 2019 May; 35(5):573-584. PubMed ID: 31282211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A heterodimer comprised of two bovine lactoferrin antimicrobial peptides exhibits powerful bactericidal activity against Burkholderia pseudomallei.
    Puknun A; Bolscher JG; Nazmi K; Veerman EC; Tungpradabkul S; Wongratanacheewin S; Kanthawong S; Taweechaisupapong S
    World J Microbiol Biotechnol; 2013 Jul; 29(7):1217-24. PubMed ID: 23404819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia.
    Crowe A; McMahon N; Currie BJ; Baird RW
    Int J Antimicrob Agents; 2014 Aug; 44(2):160-2. PubMed ID: 24924662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural effects and antibiofilm activity of LFchimera against Burkholderia pseudomallei.
    Puknun A; Kanthawong S; Anutrakunchai C; Nazmi K; Tigchelaar W; Hoeben KA; Veerman EC; Bolscher JG; Taweechaisupapong S
    World J Microbiol Biotechnol; 2016 Feb; 32(2):33. PubMed ID: 26754671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility of Burkholderia pseudomallei isolates in Northern Vietnam.
    Nhung PH; Van VH; Anh NQ; Phuong DM
    J Glob Antimicrob Resist; 2019 Sep; 18():34-36. PubMed ID: 30685463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility pattern of clinical isolates of Burkholderia pseudomallei in Bangladesh.
    Dutta S; Haq S; Hasan MR; Haq JA
    BMC Res Notes; 2017 Jul; 10(1):299. PubMed ID: 28728591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antimicrobial activity of natural toxins and animal venoms tested against Burkholderia pseudomallei.
    Perumal Samy R; Pachiappan A; Gopalakrishnakone P; Thwin MM; Hian YE; Chow VT; Bow H; Weng JT
    BMC Infect Dis; 2006 Jun; 6():100. PubMed ID: 16784542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growing Burkholderia pseudomallei in biofilm stimulating conditions significantly induces antimicrobial resistance.
    Sawasdidoln C; Taweechaisupapong S; Sermswan RW; Tattawasart U; Tungpradabkul S; Wongratanacheewin S
    PLoS One; 2010 Feb; 5(2):e9196. PubMed ID: 20169199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane-active mechanism of LFchimera against Burkholderia pseudomallei and Burkholderia thailandensis.
    Kanthawong S; Puknun A; Bolscher JG; Nazmi K; van Marle J; de Soet JJ; Veerman EC; Wongratanacheewin S; Taweechaisupapong S
    Biometals; 2014 Oct; 27(5):949-56. PubMed ID: 24961697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility patterns of Burkholderia pseudomallei among melioidosis cases in Kedah, Malaysia.
    Hassan MR; Vijayalakshmi N; Pani SP; Peng NP; Mehenderkar R; Voralu K; Michael E
    Southeast Asian J Trop Med Public Health; 2014 May; 45(3):680-8. PubMed ID: 24974653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application.
    Nell MJ; Tjabringa GS; Wafelman AR; Verrijk R; Hiemstra PS; Drijfhout JW; Grote JJ
    Peptides; 2006 Apr; 27(4):649-60. PubMed ID: 16274847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of colony morphology variation of Burkholderia pseudomallei on intracellular survival and resistance to antimicrobial environments in human macrophages in vitro.
    Tandhavanant S; Thanwisai A; Limmathurotsakul D; Korbsrisate S; Day NP; Peacock SJ; Chantratita N
    BMC Microbiol; 2010 Nov; 10():303. PubMed ID: 21114871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antibiotics of choice for the treatment of melioidosis in Indian set up.
    Shaw T; Tellapragada C; Eshwara VK; Bhat HV; Mukhopadhyay C
    Indian J Med Microbiol; 2016; 34(3):353-4. PubMed ID: 27514960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Farnesol increases the susceptibility of Burkholderia pseudomallei biofilm to antimicrobials used to treat melioidosis.
    Castelo-Branco DS; Riello GB; Vasconcelos DC; Guedes GM; Serpa R; Bandeira TJ; Monteiro AJ; Cordeiro RA; Rocha MF; Sidrim JJ; Brilhante RS
    J Appl Microbiol; 2016 Mar; 120(3):600-6. PubMed ID: 26669506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Burkholderia pseudomallei isolated in Thailand and Malaysia.
    Radua S; Ling OW; Srimontree S; Lulitanond A; Hin WF; Yuherman ; Lihan S; Rusul G; Mutalib AR
    Diagn Microbiol Infect Dis; 2000 Nov; 38(3):141-5. PubMed ID: 11109011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological cut-off value of clinical isolates of Burkholderia pseudomallei from Northern Queensland to meropenem, ceftazidime, trimethoprim/sulfamethoxazole and doxycycline by the microbroth dilution method.
    Maloney S; Engler C; Norton R
    J Glob Antimicrob Resist; 2017 Sep; 10():291-294. PubMed ID: 28729203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of Clinical Isolates of
    Sengyee S; Saiprom N; Paksanont S; Limmathurotsakul D; Wuthiekanun V; Chantratita N
    Am J Trop Med Hyg; 2017 Jul; 97(1):62-67. PubMed ID: 28719324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.